Mirna targets of prostate cancer

Methods in Molecular Biology

Volumn 936, Issue , 2013, Pages 357-369

  Deng, Jia Han ^a   Deng, Qinggao ^a   Kuo, Chih Hao ^a   Delaney, Sean W ^a   Ying, Shao Yao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Microrna; Prostate cancer; Therapeutics

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 15A; MICRORNA 16; MICRORNA 205; MICRORNA 221; MICRORNA 222; MICRORNA 23B; MICRORNA 302; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTACT INHIBITION; DNA METABOLISM; DNA REPLICATION; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; METASTASIS; NASOPHARYNX CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; UPREGULATION;

EID: 84934437599     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-83-0_27     Document Type: Article

References (59)

1. Hellerstedt BA, Pienta KJ (2002) The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52:154-179
2. Mawakyoma HA, Mabandi JL (2010) Prostate cancer; correlation of gleason's score and pretreatment prostate specific antigen in patients. Prof Med J 17:235-240
3. Feldman BJ, Feldman D (2001) The development of androgen independent prostate cancer. Nat Rev 1:34-45
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
5. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsely PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773
6. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP (2005) The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310:1817-1821
7. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz W (2005) Inhibition of translational initiation by let-7 microRNA in human cells. Science 309:1573-1576
8. Humphreys DT, Westman BJ, Martin DIK, Preiss T (2008) Inhibition of translation initiation by a microRNA. In: Appasani K (ed) MicroRNAs: from basic science to disease biology, 1st edn. Cambridge University Press, Cambridge, UK, pp 85-101
9. Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineei J, Chaudhuri A, Farzan-Kashani R, Zuker M, Pasquinelli AE, Ruvkun G, Sharp PA, Tabin CJ, McManus MT (2004) MicroRNAresponsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 36:1079-1083
10. Yekta S, Shih IH, Bartel DP (2004) MicroRNAdirected cleavage of HOXB8 mRNA. Science 304:594-596
11. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE (2004) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122:553-563
12. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623-634
13. Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, Enright AJ, Schier AF (2006) Zebrafish miR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312:75-79
14. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Fernando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2004) MicroRNA expression profiles classify human cancers. Nature 435:834-838
16. Polyak K (2007) Breast cancer: origins and evolution. J Clin Invest 117:3155-3166
17. Huang Y, Green E, Stewart TM, Goodwin AC, Baylin SB, Woster PM, Casero RA Jr (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silence genes. Proc Natl Acad Sci USA 104:8023-8028
18. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692
19. Fucito A, Lucchetti C, Giordano A, Romano G (2008) Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice? Int J Biochem Cell Biol 40:565-575
20. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Elbert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-838
21. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumor defines cancer gene targets. Proc Natl Acad Sci USA 203: 2257-2261
22. Fu X, Xue C, Huang Y, Xie Y, Li Y (2010) The activity and expression of microRNAs in prostate cancers. Mol Biosyst 6:2561-2572
23. Gandellini P, Folini M, Zaffaroni N (2009) Towards the definition of prostate cancerrelated microRNAs: where are we now? Trends Mol Med 15:381-390
24. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R (2008) The miR- 15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14:1271-1277
25. Cimmino A, Calin GA, Fabbri M, Iorlo MV, Ferracin M, Shimizu M, Wojclk SE, Aqellan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) miR-15 and miR-16 induce apoptosis by targetting BCL2. Proc Natl Acad Sci USA 102:13944-13949
26. Linsley PS, Schelter J, Buchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H, Chau N, Cleary M, Jackson AL, Carleton M, Lim L (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27:2240-2252
27. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67:6130-6135
28. Shi XB, Tepper CG, White RW (2008) MicroRNAs and prostate cancer. J Cell Mol Med 12:1456-1465
29. Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT (2010) The miR- 15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 402:491-509
30. Takeshita F, Patrawala L, Osaki M, Takahashi R, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D (2010) Systemic delivery of synthetic microRNA-16 inhibits the growth of metastasic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18:181-187
31. Wang KC, Garmire LX, Young A, Nguyen P, Trinh A, Sbramaniam S, Wang N, Shyy J, Chien S (2010) Role of microRNA-23b in fl ow-regulation of Rb phosphorylation and endothelial cell growth. Proc Natl Acad Sci USA 107:234-3239
32. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SN, De Petro G, Barlati S (2009) MicroRNA-23b mediates urokinase and C-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276:2966-2982
33. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi K, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expresion and glutamine metabolism. Nature 458:762-766
34. Leite KRM, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sanudo A, Antunes AA, Srougi M (2009) Change in expression of miR-1et7c, miR-100, and miR- 218 from high grade localized prostate cancer to metastasis. Urol Oncol 29:265-269
35. Leite KRM, Tomiyama A, Reis ST, Sousa- Canavez JM, Sanudo A, Dall'Oglio MF, Camara-Lopes LH, Srougi M (2011) MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol 185:1118-1122
36. Shi W, Alajez NM, Bastianutto C, Hui ABY, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu F (2010) Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 126:2036-2048
37. Li L, Chen XP, Li YJ (2010) MicroRNA-146a and human disease. Scand J Immunol 71: 227-231
38. Akao Y, Nakagawa Y, Naoe Y (2006) MicroRNAs 143 and 145 are possible common onco-mircoRNAs in human cancers. Oncol Rep 16:845-850
39. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avances C, Villalba M, Culine S, Fajas L (2009) miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PloS ONE 4:1-8
40. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, Dean NM, Freier SM, Bennett CF, Lollo B, Griffey R (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361-52365
41. Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, Majid S, Liu J, Khatri G, Tanaka Y, Dahiya R (2010) The functional significance of microRNA-145 in prostate cancer. Br J Cancer 103:256-264
42. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T (2007) Downregulation of microRNAs- 143 and -145 in B-cell Malignancies. Cancer Sci 98:1914-1920
43. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070
44. Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng L, Zhou H, Zhao RC (2009) miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol 34:1461-1466
45. Sachdeva M, Mo YY (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387
46. William AE, Perry MM, Moschos SA, Larner- Svensson HM, Lindsay MA (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36:1211-1215
47. Lin SL, Chiang A, Chang D, Ying SY (2008) Loss of miR-146a function in hormonerefractory prostate cancer. RNA 14: 417-424
48. Rosa A, Spagnoli FM, Brivanlou AH (2009) The miR-430/427/302 family controls mesendodermal fate specification via speciesspecific target selection. Dev Cell 16: 517-527
49. Lin SL, Chang DC, Ying SY, Leu D, Wu DTS (2010) MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 70:9473-9482
50. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DTS, Chen DT, Ying SY (2008) MiR-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14:2115-2124
51. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Golecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG, Zaffaroni N (2009) miR-205 exerts tumor suppressive functions in human prostate cancer through down-regulation of protein kinase c-epsilon. Cancer Res 69:2287-2295
52. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA, Farace MG (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targetting p27Kip1. J Biol Chem 282:23716-23724
53. Spahn M, Kneitz S, Scholz CJ, Stenger N, Rudiger T, Strobel P, Riedmiller H, Kneitz B (2010) Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 127:394-403
54. Sun T, Wang Q, Balk S, Brown M, Lee G-SM, Kantoff P (2009) The role of microRNA-221 and microRNA-222 in androgen independent prostate cancer cell lines. Cancer Res 69: 3356-3363
55. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M, Bonanno E, Muto G, Frajese GV, De Maria R, Spagnoli LG, Farace MG, Ciafre SA (2008) The inhibition of the highly expressed mir-221 and mir 222 impairs the growth of prostate carcinoma xenografts in mice. PloS ONE 3:1-10
56. Petrocca F, Lieberman J (2009) Micromanipulating cancer: microRNA-based therapeutics? RNA Biol 6:335-340
57. Wang V, Wu W (2009) MicroRNA-based therapeutics for cancer. BioDrugs 23:15-23
58. Seto AG (2010) The road towards microRNA therapeutics. Int J Biochem Cell Biol 42:1298-1305
59. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY (2004) Rho/Rhotekin-mediated NF- e B activation confers resistance to apoptosis. Oncogene 23:8731-8742